March 6, 2025

Biodesix improved sales, cut losses in fourth quarter, fiscal 2024

Tunee Pelletier, a Biodesix employee, holds a blood sample ready to be processed for genomic testing. (Courtesy Biodesix)
By

Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung disease, improved its top and bottom line results in the fourth quarter of 2024 and for the full fiscal year.

A Maryland native, Lucas has worked at news agencies from Wyoming to South Carolina before putting roots down in Colorado.
Categories: Life Sciences Louisville Today's News Biodesix Inc.

Related Posts

Sign up for BizWest Daily Alerts